Series A funding – Discover Pharma

Welcome to Discover Pharma! Today is : March 12, 2026

Series A funding

Clinical Development,Data Management,Digital Health,Movers & Shakers,Technology and platforms
IgniteData appoints Laura Hilty as CSO and Joe Lengfellner as CPO amid Series A funding close
IgniteData has appointed Laura Hilty as chief strategy officer and [...]

February 11, 2026
European biotech,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development
Enhanced Genomics extends Series A to $19m to advance autoimmune therapeutics pipeline
Enhanced Genomics has secured an additional funding round, bringing its [...]

September 22, 2025
Artificial Intelligence,Clinical Development,Global health,Medical devices,Partnerships & Funding
Magentiq Eye secures Series A funding to advance AI-powered colonoscopy solutions
Investment led by aMoon will support US and EU commercialisation [...]

August 1, 2025
Artificial Intelligence,Clinical Development,Oncology,Partnerships & Funding,Precision medicine
One Biosciences raises €15M to advance AI-driven single-cell oncology platform
One Biosciences, a precision oncology techbio company specialising in clinical-grade [...]

July 17, 2025
Artificial Intelligence,Cell & Gene Therapy,Clinical Trials,Drug Development
Vivodyne raises $40M to advance human tissue testing as alternative to animal models
Vivodyne has secured $40 million in Series A funding to [...]

May 29, 2025
Patient Centricity,Technology and platforms,Uncategorised
SpotitEarly targets US market with AI-canine breath test for early cancer detection
A biotech company combining artificial intelligence with canine scent detection [...]

May 22, 2025
Artificial Intelligence,Clinical Trials
PhaseV raises $50M to expand AI-powered clinical trial platform
PhaseV has secured $50 million in Series A funding to [...]

May 13, 2025

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK